Market Place
Sourcing Support
Milla and Alter Announce Yet Another “First Cycle” FDA Approval for Dexmedetomidine Hydrochloride Injection
09 Jun 2023 //
BUSINESSWIRE
Milla`s Generic Dexmedetomidine HydrochlorideReceives Approval in the U.S.
07 Jun 2023 //
FDA
Milla and the Alter Announce Launch of a Generic Version of Magnesium Sulfate
20 Mar 2023 //
BUSINESSWIRE
Milla and Alter Group Announce First Paragraph IV Filing and Acceptance by FDA
26 Oct 2022 //
BUSINESSWIRE
Milla Pharma`s Generic Pyridostigmine Bromide Receives Approval in U.S.
19 Apr 2022 //
FDA
Milla Pharma`s Generic Pyridostigmine Bromide Receives Approval in the U.S.
19 Apr 2022 //
FDA
Third ANDA Approval for Milla Pharma and 4th U.S. Approval for Alter Pharma
19 Apr 2022 //
BUSINESSWIRE
Milla Pharma Announces Approval of a Generic Version of Magnesium Sulfate
09 Nov 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.